Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company reported a net income for Q1, compared to a loss last year.
Trxade reported a net income of $21.25 million for the three months ended March 31, 2024, compared to a loss of $0.68 million in the corresponding period of the prior fiscal year. On a per-share basis, earnings were $16.77 per share in the first quarter, compared to a loss of $1.01 per share in the prior-year quarter.
Net income from discontinued operations, related to divestitures, was $27.88 million. The company did not generate any revenues during the quarter.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The
Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the
Summary: Tesla (TSLA) reports Q1 2025 production, deliveries
Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products
